Cutaneous and mucosal aphthosis during temsirolimus therapy for advanced renal cell carcinoma: review of cutaneous and mucosal side effects of mTOR inhibitors.
about
Cutaneous and mucosal aphthosis during temsirolimus therapy for advanced renal cell carcinoma: review of cutaneous and mucosal side effects of mTOR inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cutaneous and mucosal aphthosi ...... de effects of mTOR inhibitors.
@en
Cutaneous and mucosal aphthosi ...... de effects of mTOR inhibitors.
@nl
type
label
Cutaneous and mucosal aphthosi ...... de effects of mTOR inhibitors.
@en
Cutaneous and mucosal aphthosi ...... de effects of mTOR inhibitors.
@nl
prefLabel
Cutaneous and mucosal aphthosi ...... de effects of mTOR inhibitors.
@en
Cutaneous and mucosal aphthosi ...... de effects of mTOR inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Cutaneous and mucosal aphthosi ...... de effects of mTOR inhibitors.
@en
P2093
A De Masson
J N Dauendorffer
L Méry-Bossard
N Fouchard
P2860
P356
10.1159/000329902
P577
2011-08-16T00:00:00Z